Form 8-K
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

May 3, 2004

Date of report (date of earliest event reported)

 


 

QUADRAMED CORPORATION

(Exact Name of Registrant as Specified in Charter)

 


 

Delaware   0-21031   52-1992861

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

12110 Sunset Hills Road, Suite 600, Reston, VA 20190

(Address of Principal Executive Offices)

 

(703) 709-2300

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former Name or Former address, if Changed Since Last Report)

 



Table of Contents

TABLE OF CONTENTS

 

ITEM 5. OTHER EVENTS

  3

SIGNATURES

  4

EXHIBIT INDEX

  5

EXHIBIT 99.1

   

 

2


Table of Contents

ITEM 5. OTHER EVENTS

 

The following information is being furnished pursuant to Item 5.

 

On May 3, 2004, QuadraMed Corporation announced the resolution of the previously disclosed investigation by the United States Securities and Exchange Commission concerning the Company. The Company has consented to the issuance of a Cease and Desist Order, without admitting or denying the findings in the Order. A copy of the press release is furnished as exhibit 99.1 to this report.

 

The information in this Current Report on Form 8-K is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

 

3


Table of Contents

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: May 4, 2004

 

QuadraMed Corporation

/s/ John C. Wright


John C. Wright,

Chief Financial Officer and Corporate Secretary

 

4


Table of Contents

EXHIBIT INDEX

 

Exhibit No.

 

Description


99.1   Press Release, issued May 3, 2004, by QuadraMed Corp.

 

5